#STATMadness is back!
Our bracket-style tournament to find the best innovations in science & medicine from research institutions nationwide. Innovations must be published in 2026. Top 64 will be picked to compete based on originality, scientific rigor, and potential impact. bit.ly/4jasBRT
1
2,423
“Hospitals do not have to choose between protecting hospital staff and preserving patient/family trust in the institution.” trib.al/mubkfPq
1
612
The latest product from the tobacco industry is a flavorful nicotine tablet that melts in your mouth, allowing users to get a buzz as discreetly as popping a mint trib.al/or1K5XP
788
An unexpected patient death rattled researchers who sought to pierce the blood-brain barrier. Now some think they have a better way of mitigating risks. trib.al/XrNhtbv
The Trump administration proposed new regulations Monday that top officials say would “prevent fraud, remove bad actors, and protect the Americans who rely on” Medicare, Medicaid, and the Affordable Care Act marketplaces. bit.ly/4faDBwi
Versant Ventures, Eli Lilly, and a handful of other investors announced that they have poured $100 million into a new startup devoted to solving a gene therapy challenge that has ensnared many well-funded academics and biotechs before it. bit.ly/4jktM1c
New Trump regulation promises to crush ‘fraudsters.’ All the savings come from Medicare Advantage. trib.al/uaTTsJk
1,783
The FDA approved a new breast cancer drug from Roche, teeing up the launch of a medicine that the Swiss company has said could become its top-selling product ever. statnews.com/2026/11/16/fda-…
"We already know what works for physicians, and it isn’t any of that level one relaxation stuff." statnews.com/2026/11/16/doct…
Health care providers turn to the courts to get paid, and how insurance costs are eating your paycheck. trib.al/fcBxgRh
1
1,661
We ranked the 25 most valuable publicly traded Chinese drugmakers focused on discovering and developing proprietary medicines. statnews.com/china-biotech-i…
1
1,537
The FDA approved a new breast cancer drug from Roche, teeing up the launch of a medicine the company has said could become its top-selling product ever. trib.al/xjYSn3T
#HLTHUSA is underway! On Wednesday, STAT brings its health tech reporting to the stage with live conversations led by @brittanytrang, Mario Aguilar, and @matthewherper, featuring leaders from Epic, @WHOOP, Verily, Andor Health, and more.
Join us from 9:30–11:30 a.m. PT in the Startup Acceleration Zone. RSVP here: hlth.com/events/usa/agenda/s…

ALT This image features nine speakers for the "STAT @ HLTH" event, each with their name, title, and company. From top to bottom and left to right: Brendan Keeler of HTD Health, Aneesh Chopra of Andor Health, Ami Bhatt of Whoop, Haider Warraich of ARPA-H, Carolyn Jasik of Verily Health, Seth Howard of Epic, Antonia Papajani of Epic, Kristen Valdes of b.well Connected Health, and Lisa Bari of Innovacer. The background is blue with the event details at the bottom.
A proposal by the Trump administration to cap the amount of time foreign students and scholars can spend in the country has been struck down in court. trib.al/ArpNu6k
1,630
A proposal by the Trump administration to cap the amount of time foreign students and scholars can spend in the country has been struck down in court. statnews.com/2026/11/16/judg…
1
1,637
After spending a tumultuous two years entangled in many of the most consequential health and science policy debates of President Trump’s second term, the Association of American Medical Colleges isn’t ready to let its guard down after the Democrats won in the midterms. bit.ly/4zJdnIZ
1
1,523
The supplement NAC has been widely available for years, but exists in a legal grey area. trib.al/xzV6cic
1
4
2,233
How obesity medications may become the next big battleground over access to medicines in lower-income countries. trib.al/aj2I0HX
2
2
1,465
The acting director of NIAID, John Powers III, will become the permanent director, the agency announced Monday. trib.al/fTarSWF
The Michigan Democrat emphasized that he is hopeful the U.S. can fix its growing trust-in-science problem, but he expressed frustration — at RFK Jr., at drug and insurance companies, and at the field of public health.
Read the interview: bit.ly/3X6S5Hm
Biotech is having a good year, though you wouldn't necessarily know it from how investors are treating positive clinical data. trib.al/QIQnZyQ
4
1,757


